VV-hemorphin-7(75808-67-2)
- Name: VV-hemorphin-7
- Synonyms:L-Phenylalanine,N-[N2-[N2-[N-[N-[1-[N-(N-L-valyl-L-valyl)-L-tyrosyl]-L-prolyl]-L-tryptophyl]-L-threonyl]-L-glutaminyl]-L-arginyl]-;11: PN: WO02063305 SEQID: 3 unclaimed sequence; 15: PN: DE10133576 SEQID: 15claimed protein; 1: PN: CN101210047 SEQID: 1 claimed sequence; 29: PN:WO03011304 TABLE: 2 claimed protein; 2: PN: US20030219447 TABLE: A claimedsequence; 2: PN: WO03006492 SEQID: 2 claimed protein; 2: PN: WO2004055042SEQID: 2 claimed protein; 68: PN: WO2005116051 SEQID: 68 claimed sequence; 86:PN: US20090004213 SEQID: 86 unclaimed sequence; 8: PN: WO2007024946 SEQID: 8unclaimed sequence; VV-haemorphin-7; VV-hemorphin-7; VVH-7
- Molecular Formula:C59H82 N14 O13
- Molecular Weight:1195.37
- CAS Registry Number:75808-67-2
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 92170-23-5/somatotropin releasing hormone, N(alpha) biotinyl(1-44)amide
- 12238-50-5/C.I. Acid Black 112
- 530-66-5/quinolinium hydrogen sulphate
- 54789-96-7/1-{4-[(1-methylethyl)sulfanyl]phenyl}-2-(octylamino)butan-1-ol hydrochloride
- 14883-82-0/N-naphthalen-2-ylmethioninamide
- 1249-81-6/THIOCHOLESTEROL
- 40262-29-1/2-(Benzylamino)-5-ethylpyrimidine-4,6(1H,5H)-dione
- 56875-80-0/SAS 597
- 6452-62-6/Tetrakis(p-phenoxyphenyl)stannane
- 33448-19-0/6-methyl-1,2,3,4-tetrahydronaphthalen-2-aminium chloride
- 66968-31-8/5-Ethyl-5-(2-ethyl-3-methylhexyl)-2-sodiooxy-4,6(1H,5H)-pyrimidinedione
- 85022-64-6/(+)-[1-[5-(2,5-Dihydroxyphenyl)-3-furanyl]-4-methyl-3-penten-1-yl]3-methylbutanoate
- 2442-49-1/LIGNOCERIC ACID METHYL ESTER
- 6057-11-0/N-{2-[5-methyl-2-(propan-2-yl)phenoxy]ethyl}thiophene-2-carboxamide
- 91770-75-1/Tagetes minuta, ext.
- 23143-88-6/Carbonazidic fluoride(9CI)
- 73891-08-4/(12Z)-9-Hydroxy-12-octadecenoic acid
- 86432-14-6/(2S,4aR,4bR,7R,7aS,10R,10aS,11aS,11bR,13aR)-2-hydroxy-1,1,4a,10,11a,11b-hexamethyl-1,2,3,4,4a,4b,5,7,8,9,10,10a,11,11a,11b,12,13,13a-octadecahydro-7aH-7,10-methanocyclopenta[b]chrysene-7a-carboxylic acid
- 261-89-2/Phenothiazin-5-ium
- 75808-67-2/VV-hemorphin-7
- 90218-51-2/Formaldehyde-sodium m-cresolsulfonate condensate
- 120388-18-3/alpha-bromo-4-hydroxy-3,5-dinitroacetophenone
- 90366-89-5/1,2-Ethanediamine, N,N-bis(2-aminoethyl)-, reaction products withethyloxirane
- 126703-15-9/4a-(hydroxymethyl)-8-methoxy-4,4a,5,6-tetrahydrobenzo[h]cinnolin-3(2H)-one
- 1271-03-0/Cyclopentadienyl allyl palladiuM
- 73771-78-5/4-(7-methoxy-2,3-dimethyl-4-oxo-4H-chromen-8-yl)morpholin-4-ium chloride
- 72907-24-5/BN-227-F
- 176910-62-6/1H-Indole-4-methanol, 2-methyl-3-[(2-methyl-1H-indol-4-yl)methyl]-
- 87497-25-4/4-benzylidene-1,7-bis(dimethylamino)heptane-3,5-dione
- 152607-04-0/2H-10,4a-(Epoxymethano)phenanthrene-5,8,12-trione,1,3,4,9,10,10a-hexahydro-6,9-dihydroxy-1,1-dimethyl-7-(1-methylethyl)-,(4aR,9S,10S,10aS)-